Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Neurology
»
Parkinson
24. July 2026
Search
medline.ch
Parkinson
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2916
Articles 1 - 20 / 58313
Antibody screening identifies HERV-K-related immune responses as candidate biomarkers in Parkinson's disease.
Front Cell Infect Microbiol
Simula ER, Fais M, Ercoli T, Jasemi S, Paulus K, Solla P, Pandino C, Sechi LA.
PMID: 42491523 [PubMed - indexed for MEDLINE]
GLP-1 receptor agonists in Parkinson's disease: a meta-analysis revealing motor benefit and highlighting mood improvement.
Front Neurol
Chen Y, Zhang Z, Liu Z, Lv T, Ye M, Yan J, Zhang M.
PMID: 42490867 [PubMed]
Optimal exercise modalities and dosages for improving depression in middle-aged and older adults with Parkinson's disease: A Bayesian Dose-response network meta-analysis.
PLoS One
Lyu Y, Chen J, Zeng S.
PMID: 42490648 [PubMed - indexed for MEDLINE]
Using Wearable Devices to Monitor Activity and Sleep in Inpatients With Parkinson Disease With and Without Delirium: Feasibility and Acceptability Study.
J Med Internet Res
Bate GL, Gerakios F, Yarnall AJ, Richardson SJ, Wright L, Taylor JP, Burn DJ, Stebbins G, Allan LM, Del Din S, Lawson RA.
PMID: 42490546 [PubMed - indexed for MEDLINE]
From synaptic development to degeneration: a narrative review of small molecule strategies targeting alpha-synuclein in Parkinson's disease.
Metab Brain Dis
Khoo L, Ng KY, Chye CL, Ko Y, Lee JY, Koh Y, Tsen MT, Chye SM.
PMID: 42489942 [PubMed - indexed for MEDLINE]
Large language models as a screening tool for the qualification of patients with Parkinson's disease for device-aided therapies.
J Neural Transm (Vienna)
Pobudejski P, To, Nyczka K, Duda K, Chmiela T, Siuda J.
PMID: 42489906 [PubMed - as supplied by publisher]
Plant-derived therapies in Parkinson's disease: a systematic review of clinical evidence.
J Neural Transm (Vienna)
Sukmueng N, Phokaewvarangkul O, Bhidayasiri R.
PMID: 42489905 [PubMed - as supplied by publisher]
A whole-transcriptome analysis of differentially expressed genes, transcripts, and transcript usage in blood samples from Parkinson's disease patients.
Exp Biol Med (Maywood)
Koks S, Muldmaa M, Price J, Whiley L, Jakobson M, Singleton L, Howting D, Pfaff AL, Chopra A, Watson M, Sikk K, Taba P.
PMID: 42488690 [PubMed - indexed for MEDLINE]
Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson's disease.
Front Neurol
Czech MD, Sawicki S, Zadikoff C, Liu C, Robieson W, Liu Y, Shi W, Shen J, Crouthamel M, Quinton MS, Cosman J, Dorsey ER, Adams JL, Nevler N.
PMID: 42488389 [PubMed]
Patient autonomy in advance care planning for Parkinson's disease: Systematic review with narrative synthesis.
Palliat Support Care
Bouma EZ, Schoones JW, Kaptein AA, Florijn BW.
PMID: 42487559 [PubMed - indexed for MEDLINE]
Remote Assessment of Mobility in People with Parkinson's Disease: A Feasibility, Safety, Validity, Agreement, and Reliability Study.
Mov Disord Clin Pract
Silva-Batista C, Scanlan KT, Stojak ME, Wilhelm JL, Carlson-Kuhta P, Liu W, Chen S, Horak FB, Mancini M, King LA.
PMID: 42487328 [PubMed - as supplied by publisher]
Cross-sectional analysis of variation in diagnosis of Lewy body dementia in three English regions: data from the DETERMIND programme.
BMJ Open
Hamilton CA, Thomas AJ, Donaghy PC, Hicks B, Mueller C, Banerjee S.
PMID: 42486521 [PubMed - indexed for MEDLINE]
Cognitive dysfunction in Parkinson's disease: Hippocampal vulnerability and redox-driven mechanisms.
Redox Biol
Curto AR, Silva AA, Fiadeiro MB, Pereira D, Cristóvão AC.
PMID: 42485748 [PubMed - as supplied by publisher]
Effect of continuous subcutaneous foslevodopa/foscarbidopa infusion on gait in advanced Parkinson's disease: a real-world wearable-based study.
J Neurol
Meksi K, Simonetta C, Campone J, Ferrari V, Antonucci M, Conti M, Schirinzi T, Centonze D, Avvento F, Stefani A, Pierantozzi M.
PMID: 42484650 [PubMed - indexed for MEDLINE]
Association Between Atrial Fibrillation Occurrence and Wolff-Parkinson-White Syndrome: Is Prediction Possible?
Arq Bras Cardiol
Mario ADS, Targueta EP, Darrieux FCDC, Brigido ARD, Ferraz AP, Chokr MO, Pisani CF, Scanavacca MI.
PMID: 42484212 [PubMed - indexed for MEDLINE]
Assessment of balance, sleep quality, and depression in relation to attention in Parkinson's disease: A cross-sectional P300 study.
Sao Paulo Med J
Ozaltin GE, Simsek A, Candiri B, Algul FE, Tecellioglu M, Talu B.
PMID: 42484116 [PubMed - indexed for MEDLINE]
The influence of cholesterol on the 5-year all-cause mortality of Parkinson patients with or without deep brain stimulation.
Sci Prog
Roth GC, Treven M, Brücke C, Lehrner J.
PMID: 42484026 [PubMed - indexed for MEDLINE]
Breaking the Freeze: The Role of Cognitive Function in Freezing of Gait in Parkinson's Disease.
Parkinsons Dis
Papacek O, Ruzicka E.
PMID: 42483310 [PubMed]
Loss of Neocortical Oligodendrocytes in Parkinson's Disease Patients-A Stereological Study.
J Neurosci Res
Horndrup MP, Salvesen L, Kaalund SS, Olesen MV.
PMID: 42482628 [PubMed - indexed for MEDLINE]
Differential effects of hormone therapy formulations on Parkinson's disease risk: a systematic review and meta-analysis.
Neurol Sci
Macedo VFB, de Melo Barboza AM.
PMID: 42481816 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 58313
Page 1 of 2916
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy